The Daily Docket: K-V Pharmaceutical Files for Bankruptcy

K-V Pharmaceutical Co . filed for Chapter 11 bankruptcy, a move it said was propelled by the U.S. Food and Drug Administration ‘s failure to enforce orphan drug exclusivity granted to K-V’s key premature-birth drug, Makena. Read the Dow Jones story here in Daily  Bankruptcy Review.

(Daily Bankruptcy Review and DBR Small Cap are daily newsletters with comprehensive coverage and analysis of emerging and in-progress insolvencies and turnarounds. For a two-week trial, visit our homepage, scroll to the bottom and click “try for free.”)

Knight Capital Group Inc.  confirmed that the embattled brokerage had agreed to a $400 million rescue plan that would help fill a hole left by errant trading last week. Read The Wall Street Journal story here.

Spyker NV, the owner of Swedish car maker Saab Automobile AB before its financial collapse late last year, Monday said it has filed a $3 billion lawsuit against General Motors Co.  claiming the U.S. car giant drove the Swedish company into bankruptcy, Dow Jones Newswires reports.

Some 700 former Dewey & LeBoeuf partners must decide by Tuesday whether to opt in to a proposed $90.4 million settlement plan, AmLaw Daily reports.

Court records show that the mother of Olympic gymnast Gabby Douglas filed for bankruptcy earlier this year in Virginia, The Associated Press reports.

The bankruptcy receiver hunting for Peregrine Financial Group assets hasn’t found many high-priced toys, reports Reuters.

Follow Bankruptcy Beat on Twitter.